These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29488681)

  • 1. Functional characterization of recombinant snake venom rhodocytin: rhodocytin mutant blocks CLEC-2/podoplanin-dependent platelet aggregation and lung metastasis.
    Sasaki T; Shirai T; Tsukiji N; Otake S; Tamura S; Ichikawa J; Osada M; Satoh K; Ozaki Y; Suzuki-Inoue K
    J Thromb Haemost; 2018 May; 16(5):960-972. PubMed ID: 29488681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The snake venom rhodocytin from Calloselasma rhodostoma- a clinically important toxin and a useful experimental tool for studies of C-type lectin-like receptor 2 (CLEC-2).
    Bruserud Ø
    Toxins (Basel); 2013 Apr; 5(4):665-74. PubMed ID: 23594438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells.
    Suzuki-Inoue K; Kato Y; Inoue O; Kaneko MK; Mishima K; Yatomi Y; Yamazaki Y; Narimatsu H; Ozaki Y
    J Biol Chem; 2007 Sep; 282(36):25993-6001. PubMed ID: 17616532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of polypeptides derived from a snake venom C-type lectin, aggretin, on tumor cell-induced platelet aggregation.
    Chang CH; Chung CH; Hsu CC; Peng HC; Huang TF
    J Thromb Haemost; 2014 Apr; 12(4):540-9. PubMed ID: 24479713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombomodulation via CLEC-2 targeting.
    O'Callaghan CA
    Curr Opin Pharmacol; 2009 Apr; 9(2):90-5. PubMed ID: 19091630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2.
    Kato Y; Kaneko MK; Kunita A; Ito H; Kameyama A; Ogasawara S; Matsuura N; Hasegawa Y; Suzuki-Inoue K; Inoue O; Ozaki Y; Narimatsu H
    Cancer Sci; 2008 Jan; 99(1):54-61. PubMed ID: 17944973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A platform of C-type lectin-like receptor CLEC-2 for binding O-glycosylated podoplanin and nonglycosylated rhodocytin.
    Nagae M; Morita-Matsumoto K; Kato M; Kaneko MK; Kato Y; Yamaguchi Y
    Structure; 2014 Dec; 22(12):1711-1721. PubMed ID: 25458834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of the interaction of the snake venom rhodocytin with the platelet receptor CLEC-2.
    Watson AA; O'Callaghan CA
    Toxins (Basel); 2011 Aug; 3(8):991-1003. PubMed ID: 22069753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of platelet aggregation by affinity captured rhodocytin from the Malayan pit viper Calloselasma rhodostoma.
    Feickert MK; Sanz-Soler R; Niland S; König S; Eble JA; Obermann WMJ
    Toxicon; 2023 Mar; 225():107058. PubMed ID: 36806336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel platelet activation receptor CLEC-2.
    Suzuki-Inoue K; Inoue O; Ozaki Y
    Platelets; 2011; 22(5):380-4. PubMed ID: 21714702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting a novel domain in podoplanin for inhibiting platelet-mediated tumor metastasis.
    Sekiguchi T; Takemoto A; Takagi S; Takatori K; Sato S; Takami M; Fujita N
    Oncotarget; 2016 Jan; 7(4):3934-46. PubMed ID: 26684030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel platelet antagonist that binds to CLEC-2 and suppresses podoplanin-induced platelet aggregation and cancer metastasis.
    Chang YW; Hsieh PW; Chang YT; Lu MH; Huang TF; Chong KY; Liao HR; Cheng JC; Tseng CP
    Oncotarget; 2015 Dec; 6(40):42733-48. PubMed ID: 26528756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential in vivo roles of the platelet activation receptor CLEC-2 in tumour metastasis, lymphangiogenesis and thrombus formation.
    Suzuki-Inoue K
    J Biochem; 2011 Aug; 150(2):127-32. PubMed ID: 21693546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A change of rhodocytin's suprastructure turns the agonist into an antagonist of tumor cell induced platelet aggregation.
    Obermann WMJ; König S; Feickert MK; Sanz-Soler R; Eble JA
    FASEB J; 2024 Jan; 38(2):e23402. PubMed ID: 38193585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The podoplanin-CLEC-2 interaction promotes platelet-mediated melanoma pulmonary metastasis.
    Sheng M; Sun R; Fu J; Lu G
    BMC Cancer; 2024 Apr; 24(1):399. PubMed ID: 38561690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking podoplanin suppresses growth and pulmonary metastasis of human malignant melanoma.
    Xu M; Wang X; Pan Y; Zhao X; Yan B; Ruan C; Xia L; Zhao Y
    BMC Cancer; 2019 Jun; 19(1):599. PubMed ID: 31208371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2.
    Suzuki-Inoue K; Fuller GL; García A; Eble JA; Pöhlmann S; Inoue O; Gartner TK; Hughan SC; Pearce AC; Laing GD; Theakston RD; Schweighoffer E; Zitzmann N; Morita T; Tybulewicz VL; Ozaki Y; Watson SP
    Blood; 2006 Jan; 107(2):542-9. PubMed ID: 16174766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CLEC-2-dependent activation of mouse platelets is weakly inhibited by cAMP but not by cGMP.
    Borgognone A; Navarro-Núñez L; Correia JN; Pollitt AY; Thomas SG; Eble JA; Pulcinelli FM; Madhani M; Watson SP
    J Thromb Haemost; 2014 Apr; 12(4):550-9. PubMed ID: 24460629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of rhodocytin, a ligand for the platelet-activating receptor CLEC-2.
    Watson AA; Eble JA; O'Callaghan CA
    Protein Sci; 2008 Sep; 17(9):1611-6. PubMed ID: 18583525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G
    Badolia R; Inamdar V; Manne BK; Dangelmaier C; Eble JA; Kunapuli SP
    J Biol Chem; 2017 Sep; 292(35):14516-14531. PubMed ID: 28705934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.